StockMarketWire.com - Liberum Capital today reaffirms its hold investment rating on GlaxoSmithKline PLC [LON:GSK] and raised its price target to 1930p (from 1890p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk